Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 23, 2019
CAMP4 announced a research collaboration with Alnylam focused on identifying new druggable targets to address an undisclosed rare disease of the liver with a significant unmet need.
read more
Wednesday, September 09, 2020
Catalent’s Redwood Bioscience subsidiary will develop multiple antibody-drug conjugates for Exelixis using Catalent’s proprietary SMARTag site-specific bioconjugation technology.
read more
Halozyme Therapeutics has announced that the first healthy subject has been dosed in a Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of a subcutaneous formulation of rivipansel, a compound discovered by GlycoMimetics...
read more
Catalent announced a multi-year $350 million investment at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product manufacturing capabilities. The project will serve the industry’s robust biologics pipeline across ...
read more
George Clinical announced it has rebranded to become Emerald Clinical Trials. This strategic name change underscores the company's well-established position as a dedicated, reliable, consistent, and flexible CRO, while mitigating global clinical ...
read more
Monday, December 03, 2018
KBI Biopharma and Selexis have appointed four leading, internationally recognized scientists to their newly formed Joint Scientific Advisory Board (JSAB).
read more
Thursday, February 13, 2020
Rentschler Biopharma announced the hiring of Grace Kim as Vice President Business Development – North America and APAC.
read more
Mylan has restarted production of hydroxychloroquine sulfate tablets at its West Virginia manufacturing facility.
read more
Thursday, August 16, 2018
Natera has partnered with Fox Chase Cancer Center to assess the company's Signatera customized circulating tumor DNA (ctDNA) assay for recurrence monitoring of kidney cancer.
read more
Wednesday, September 09, 2015
goBalto, Inc. has announced a two-year partnership with the Society for Clinical Research Sites (SCRS), the globe trade organization fully dedicated to representing the interests of clinical research sites.
read more
Veristat, a global clinical research organization (CRO), announced the expansion and strengthening of its service capabilities by acquiring SFL (Solutions for Life Sciences). With headquarters in Basel, Switzerland and several European affiliates, ...
read more
For patients, the new Digital Front Door software unlocks interoperability, patient access, data sharing, simplified informed consent process and boosted participant engagement. This leads to better patient retention and a lighter caregiver burden ...
read more
Hongene has appointed Dr. Pieter Cullis, a renowned innovator in lipid nanoparticle (LNP) drug delivery, to its scientific advisory board. This strategic addition reinforces Hongene’s commitment to advancing RNA therapeutics.
read more
Bioanalytical Sciences, dba Inotiv, Inc. has announced that Kenneth Swart, Ph.D., has joined the Company as Vice President, Bioanalytical Sciences.
read more
Huma Therapeutics Limited has acquired Alcedis GmbH. Through the acquisition, Huma will form an advanced clinical trials division offering digital solutions across the entire development pipeline, from early stage through to Phase IV hybrid and fully...
read more